JAGUAR HEALTH, INC.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2M | $20.3M | $3.1M | $3.0M | $2.2M | $3.1M | $2.7M | $2.4M |
| Cost of Revenue | $1.0M | $1.2M | $532.0K | $527.0K | $515.0K | $541.0K | $427.0K | $430.0K |
| Gross Profit | $194.0K | $19.1M | $2.6M | $2.5M | $1.7M | $2.6M | $2.3M | $1.9M |
| Gross Margin | 15.8% | 94.3% | 82.7% | 82.3% | 76.7% | 82.6% | 84.3% | 81.7% |
| Operating Expenses | ||||||||
| Research & Development | $3.3M | $3.9M | $3.7M | $3.3M | $3.7M | $4.0M | $3.7M | $4.3M |
| SG&A Expense | $4.5M | $4.1M | $4.1M | $4.7M | $4.9M | $3.8M | $4.3M | $4.4M |
| Operating Income | $-7.6M | $10.2M | $-7.2M | $-8.0M | $-9.4M | $-7.3M | $-7.2M | $-8.2M |
| Operating Margin | -620.2% | 50.2% | -234.8% | -268.8% | -425.5% | -233.7% | -264.5% | -349.4% |
| Interest Expense | $161.0K | $699.0K | $6.0K | $-15.0K | $-56.0K | $-162.0K | $-108.0K | $611.0K |
| Pretax Income | $-12.8M | $8.7M | $-9.6M | $-10.6M | $-10.6M | $-10.0M | $-9.6M | $-9.4M |
| Income Tax Expense | $0 | $0 | — | $0 | $0 | — | $0 | $0 |
| Net Income | $-12.8M | $8.7M | $-9.5M | $-10.4M | $-10.5M | $-9.9M | $-9.5M | $-9.2M |
| Net Margin | -1,045.1% | 43.0% | -308.2% | -349.3% | -472.6% | -317.1% | -348.8% | -392.4% |
| EPS (Basic) | $-15.70 | $-13.60 | $-0.79 | $-44.87 | $-73.06 | $-3.29 | $-0.33 | $-10.89 |
| EPS (Diluted) | $-15.70 | $-13.60 | $-0.79 | $-44.87 | $-73.06 | $-3.29 | $-0.33 | $-10.89 |
| Shares Outstanding (Basic) | 809.1K | 515.8K | 12.1M | 232.0K | 143.2K | 3.0M | 28.6M | 1.27B |
| Shares Outstanding (Diluted) | 809.1K | 515.8K | 12.1M | 232.0K | 143.2K | 3.0M | 28.6M | 1.27B |
| Dividends Per Share | — | — | — | — | — | — | — | — |